Zhitong Finance App learned that Sihuan Pharmaceutical (00460.HK) recently underwent an optimization and upgrade of its governance structure and announced the appointment of Mr. Che Yuxuan as a non-executive director of the company and a member of the Board Risk Management Committee, effective August 26, 2026. With its international research background and diverse perspectives, the addition of a new non-executive director is expected to inject new momentum into the company's commercialization of innovative drug pipelines and the empowerment of AI research and development.

Zhitong Finance App learned that Sihuan Pharmaceutical (00460.HK) recently underwent an optimization and upgrade of its governance structure and announced the appointment of Mr. Che Yuxuan as a non-executive director of the company and a member of the Board Risk Management Committee, effective August 26, 2026. With its international research background and diverse perspectives, the addition of a new non-executive director is expected to inject new momentum into the company's commercialization of innovative drug pipelines and the empowerment of AI research and development.